Fluent

Fluent Forward P/E

Delisted

The Forward P/E Ratio of Fluent (TIUM.U.CN) as of Nov 5, 2026 is -0.94. In the previous year, Forward P/E Ratio was -0.57 — a change of 64.50% (lower).

Forward P/E

-0.94

YoY

64.50%

Last updated:

Forward P/E Ratio of Fluent is 2023 -0.94 . Forward P/E Ratio of Fluent was 2022 -0.57 . It decreases by 64.50% lower compared to the previous year.

The Fluent Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
-0.33 USD
Jan 1, 2020
-0.59 USD
Jan 1, 2021
-1.13 USD
Jan 1, 2022
-0.57 USD
Jan 1, 2023
-0.94 USD
The Fluent Forward P/E history
YEARForward P/EYoY
-0.94+64.50%
-0.57-49.12%
-1.13+92.34%
-0.59+78.41%
-0.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Forward P/E Ratio of Fluent is -0.94 in 2023.

Forward P/E Ratio of Fluent changed from -0.57 to -0.94, representing a 64.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Fluent since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Fluent with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Fluent

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Fluent